首页 >
法规速递
-
关于公开征求《研发期间安全性更新报告常见问答（征求意见稿）》意见的通知-2025/9/17
2025-09-18查看详情 > -
Document: Highlights – EMA/ EASD bilateral meeting-2025/10/22
2025-10-23查看详情 > -
Document: Minutes of the COMP meeting 7-8 October 2025-2025/11/25
2025-11-26查看详情 > -
Document: Recommended submission dates for veterinary medicinal products-2026/2/2
2026-02-03查看详情 > -
Document: List of clinical evaluation consultation procedure (CECP) opinions issued for medical devices awaiting finalisation of conformity assessment-2026/3/10
2026-03-11查看详情 > -
Page: Maximum residue limits (MRL)-2026/4/8
2026-04-09查看详情 > -
关于公开征求《eCTD v4.0指导原则》意见的通知-2026/5/27
2026-05-28查看详情 > -
国家药监局关于修订磷酸/盐酸川芎嗪制剂说明书的公告（2022年第123号）-2022/12/29
2022-12-30查看详情 > -
国家药监局关于发布仿制药参比制剂目录（第七十批）的通告（2023年第31号）-2023/7/17
2023-07-21查看详情 > -
Document: ICH Q5A(R2) Guideline on viral safety evaluation of biotechnology products derived from cell lines of human or animal origin - Step 5-2024/1/3
2024-02-05查看详情 >
